These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 32423137)
21. [Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines]. Lü XQ; Suo Z; Ma CL; Xu KJ; Liu YS; Li HX Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):441-4. PubMed ID: 19781189 [TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116 [TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines. Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801 [TBL] [Abstract][Full Text] [Related]
24. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells. Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818 [TBL] [Abstract][Full Text] [Related]
25. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast. Gudadze M; Kankava Q; Mariamidze A; Burkadze G Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368 [TBL] [Abstract][Full Text] [Related]
27. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657 [TBL] [Abstract][Full Text] [Related]
28. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG. Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070 [TBL] [Abstract][Full Text] [Related]
29. Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines. Zaleska K; Suchorska WM; Przybyła A; Murawa D Oncol Lett; 2016 Nov; 12(5):3707-3714. PubMed ID: 27900058 [TBL] [Abstract][Full Text] [Related]
30. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells. Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653 [TBL] [Abstract][Full Text] [Related]
31. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. Li X; Lewis MT; Huang J; Gutierrez C; Osborne CK; Wu MF; Hilsenbeck SG; Pavlick A; Zhang X; Chamness GC; Wong H; Rosen J; Chang JC J Natl Cancer Inst; 2008 May; 100(9):672-9. PubMed ID: 18445819 [TBL] [Abstract][Full Text] [Related]
32. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature. Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177 [TBL] [Abstract][Full Text] [Related]
33. Effects of normothermic microwave irradiation on CD44 Asano M; Tanaka S; Sakaguchi M Biosci Biotechnol Biochem; 2020 Jan; 84(1):103-110. PubMed ID: 31559912 [TBL] [Abstract][Full Text] [Related]
34. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells. Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation. Moreira MP; Brayner FA; Alves LC; Cassali GD; Silva LM Eur Biophys J; 2019 Oct; 48(7):673-684. PubMed ID: 31485678 [TBL] [Abstract][Full Text] [Related]
36. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433 [TBL] [Abstract][Full Text] [Related]
37. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Chekhun S; Bezdenezhnykh N; Shvets J; Lukianova N Exp Oncol; 2013 Sep; 35(3):174-9. PubMed ID: 24084454 [TBL] [Abstract][Full Text] [Related]